These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26006718)

  • 41. Eosinophilic cardiac disease: Molecular, clinical and imaging aspects.
    Séguéla PE; Iriart X; Acar P; Montaudon M; Roudaut R; Thambo JB
    Arch Cardiovasc Dis; 2015 Apr; 108(4):258-68. PubMed ID: 25858537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Induced by Levetiracetam in a Pediatric Patient.
    Bayram AK; Canpolat M; Çınar SL; Tahan F; Gumus H; Kumandaş S; Per H
    J Emerg Med; 2016 Feb; 50(2):e61-6. PubMed ID: 26597350
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?
    Martínez-Cabriales SA; Rodríguez-Bolaños F; Shear NH
    Am J Clin Dermatol; 2019 Apr; 20(2):217-236. PubMed ID: 30652265
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms.
    Corneli HM
    Pediatr Emerg Care; 2017 Jul; 33(7):499-502. PubMed ID: 28665896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).
    Bocquet H; Bagot M; Roujeau JC
    Semin Cutan Med Surg; 1996 Dec; 15(4):250-7. PubMed ID: 9069593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DRESS syndrome: Part I. Clinical perspectives.
    Husain Z; Reddy BY; Schwartz RA
    J Am Acad Dermatol; 2013 May; 68(5):693.e1-14; quiz 706-8. PubMed ID: 23602182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review.
    Bommersbach TJ; Lapid MI; Leung JG; Cunningham JL; Rummans TA; Kung S
    Mayo Clin Proc; 2016 Jun; 91(6):787-801. PubMed ID: 27126302
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
    Maloney NJ; Rana J; Yang JJ; Zaba LC; Kwong BY
    Support Care Cancer; 2022 Mar; 30(3):2839-2851. PubMed ID: 34546454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    Sharpe A; Mourad BM; Hardwick CJ; Reilly T; Dweck E; Bondarsky E
    Am J Case Rep; 2019 Mar; 20():345-348. PubMed ID: 30877266
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DRESS syndrome.
    Descamps V; Ranger-Rogez S
    Joint Bone Spine; 2014 Jan; 81(1):15-21. PubMed ID: 23816504
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma.
    Kohlmann J; Reschke R; Mockenhaupt M; Ziemer M
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e242-e244. PubMed ID: 34704628
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
    Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
    J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug rash with eosinophilia and systemic symptoms (DRESS) caused by phenytoin.
    Riaz M; Ragsdale BD; Rahman ZU; Nigam G
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28830901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS].
    Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF
    Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
    Kano Y; Shiohara T
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Drug reaction with eosinophilia and systemic symptoms].
    Tehrany YA; Laffitte E; Grosgurin O; Spoerl D
    Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
    Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
    Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug reaction with eosinophilia and systemic symptoms in a child on multiple antiepileptics.
    Goswami JN; Vaidya PC; Saini AG; De D; Radotra BD; Singhi PD
    Turk J Pediatr; 2017; 59(2):197-199. PubMed ID: 29276875
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [DRESS in intensive care unit: a challenging diagnosis and treatment].
    Derlon V; Audibert G; Barbaud A; Mertes PM
    Ann Fr Anesth Reanim; 2014 Dec; 33(12):693-5. PubMed ID: 25450727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential Biomarker Identification by RNA-Seq Analysis in Antibiotic-Related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Pilot Study.
    Teo YX; Haw WY; Vallejo A; McGuire C; Woo J; Friedmann PS; Polak ME; Ardern-Jones MR
    Toxicol Sci; 2022 Aug; 189(1):20-31. PubMed ID: 35703984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.